Sanofi CEO meets Genzyme holders, mulls next moveReutersO) by meeting shareholders of the US biotech company face to face, the French company said Tuesday. Genzyme last week rejected an all-cash $18.5 billion …
and more »

Technorati Tags: Biotech, Biotech USA

Genzyme CEO says sale possible, at the right priceBoston Globe… this morning that the Cambridge biotechnology company could be sold — but not at the $69 a share price offered Sunday by France’s Sanofi-Aventis SA. …
and more »

Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersSeptember 5, 2010 — Sanofi [...]

Stallergenes hunts for US partnerFierceBiotechThe search will begin in Q4 after the France-based company meets with the FDA. CEO Albert Saporta says Stallergenes has retained Torreya Partners to help …
and more »

Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersSeptember 7, 2010 — FDA reverses decision to pull Shire drug; [...]

Biocept Targets Spreading Tumors With Advance in DiagnosticsSan Diego Union TribuneThat news reminded me of a fascinating meeting I had in June with Biocept CEO Stephen Coutts, a 30-year veteran of San Diego’s biotech community. …
and more »

Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersJuly 27, 2010 — Cerenis' [...]

Sanofi CEO targeting everything but blockbustersThe Associated PressAnother source with knowledge of the talks told the AP that talks with the Cambridge, Mass., biotech company are continuing and an announcement is not …
and more »

Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersSeptember 3, 2010 — Scenarios: Possible outcomes of [...]

Cerenis’ Series C Adds €40M for HDL Mimetic in CV DiseaseBioWorld OnlineTo date, Toulouse, France-based Cerenis has raised €107 million. Co-founder and CEO Jean-Louis Dasseux attributed investor interest to the management team, …
and more »

Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersAugust 20, 2010 — Biocept Targets Spreading Tumors [...]

Outsource to EuropePharmiWeb.com (press release)Simon Orchard the : VP Biotech Operating Unit Europe and Managing Director of the Strängnäs site (Sweden) and CEO for Pfizer Health AB is only to aware of …

Related PostsJanuary 11, 2010 — PharmaNet Development Group Symposia 'Crossing the Bridge from Preclinical to … – PR Newswire (press release)August 12, 2010 [...]

NewsWatch: Aeras names Connolly new CEO and presidentBusiness GazetteIn previous years, biotech executives camped out on line for up to five days to apply for the credit. For fiscal 2011, which started Thursday, …

Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersAugust 31, 2010 — Genzyme CEO says sale [...]

From Antivirus To Antibiotics, McAfee Searches For A Last CureGizmodo AustraliaWhat would possess a person – the CEO of a fledgling biotech firm – to think this was the best way to introduce himself to an already sceptical reporter? …

Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersSeptember 3, [...]

YM BioSciences Reshuffles the Cytopia DeckThe Market FinancialMr. Allan also suggests that Dr. Glover, 40, a former CEO of Viventia Biotech, has all the right credentials in manufacturing, chemistry and pivotal …

Related PostsSeptember 7, 2010 — Sanofi CEO meets Genzyme holders, mulls next move – ReutersAugust 31, 2010 — Genzyme CEO says sale possible, at [...]